Peter Heerma, CHIEF COMMERCIAL OFFICER at Travere Therapeutics, Inc. (TVTX), sold 6,669 shares at $35.00 ($196K) on 2025-10-31, disclosed to the SEC on 2025-11-04.
Scheduled sale ($196k) by CHIEF COMMERCIAL OFFICER under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $35.00 | 5,591 | $196K | 100.0% |
| 2 | $0.00 | 1,078 | $0 | 0.0% |
| Total | $29.34 avg | 6,669 | $196K | 100% |
| Filing → |
| TVTX | SELL | 2026-04-15 | $303K | — | Filing → |
| TVTX | SELL | 2026-02-03 | $235K | — | Filing → |
| TVTX | SELL | 2025-12-29 | $199K | — | Filing → |